"VRTierOne" as a Method Supporting the Post-stroke Rehabilitation

NCT03830372 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2020-06-23

No results posted yet for this study

Summary

Thanks to using VR googles and the phenomenon of total immersion "VR Tier One" allows to completely separate the patient from the hospital environment, provides an intense visual, auditory and kinesthetic stimulation. Depending on the stage of therapy it can have a calming and mood-improving effect or, in another part of the game, it can motivate and cognitively activate the patient. The additional aim of the game is to help the patients regain their emotional balance, let them recognize their resources in order to bring them to power in the rehabilitation process and trigger the natural recovery mechanisms.

Conditions

Interventions

DEVICE

VR Tier One

10 sessions of 20 minutes virtual terapeutic game Thanks to using VR googles and the phenomenon of total immersion VR Tier One terapy game allows to completely separate the patient from the hospital environment and provides an intense visual, auditory and kinesthetic stimulation. Depending on the stage of therapy it can have a calming and mood-improving effect or it can motivate and cognitively activate the patient. The additional aim of the game is to help the patients regain their emotional balance, let them recognize their resources in order to bring them to power in the rehabilitation process and trigger the natural recovery mechanisms.

OTHER

Control

10 sessions of 20 minutes of Schultz Autogenic Training

Sponsors & Collaborators

  • National Center for Research and Development, Poland

    collaborator OTHER
  • Przedsiębiorstwo Produkcyjno Usługowe STOLGRAF

    collaborator UNKNOWN
  • IRCCS San Camillo, Venezia, Italy

    collaborator OTHER
  • Foundation for Senior Citizen Activation SIWY DYM

    collaborator OTHER
  • Wroclaw University of Health and Sport Sciences

    lead OTHER

Principal Investigators

  • Joanna Szczepańska-Gieracha, prof · University School of Physical Education, Poland

  • Joanna Szczepańska-Gieracha, prof · University School of Physical Education, Poland

  • Pawel Kiper, PhD · Fondazione Ospedale San Camillo IRCCS

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-06
Primary Completion
2020-04-03
Completion
2020-04-03

Countries

  • Italy
  • Poland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03830372 on ClinicalTrials.gov